Oxford University begins clinical trials for Bundibugyo Ebola vaccine
Compare the reporting
Significant discrepancy in infection and death counts.
Open the listed sources to review each publisher’s original wording.
Story essentials
Oxford University / WHO
Democratic Republic of Congo / Uganda
July 24, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 17/29/2026, 7:11:06 PM
Oxford University has administered the first dose of a vaccine targeting the Bundibugyo strain of Ebola. The outbreak in DRC and Uganda has caused over 1,270 deaths and nearly 3,000 infections since May. The vaccine candidate was developed in eight weeks using technology similar to the AstraZeneca Covid-19 vaccine. WHO warns that the actual number of cases could be twice as high due to conflict-related access issues.
Read next
Prioritized by shared people, places, and events.
JMA Earthquake Alert: Kumamoto Prefecture
JMA reported an earthquake in Kumamoto Prefecture. Seismic intensity scale recorded as 4 out of 7.